We have previously shown that the sulfide metabolite of sulindac can induce NF-κB and AP-1 (c-Jun and JunD) signalling in colon cancer cells, which lead to upregulation of the chemokine IL8 (Mladenova et al., 2011, , 2013). Here, NFKB1 is linked to malignant colon neoplasm.